VEGFA and ovarian carcinoma: Our previous studies found that ASP significantly reduced the cellular adhesive and invasive abilities of ovarian cancer cells and decreased the expression of VEGF in tumor tissues of a transgenic mouse model of ovarian cancer (Xu et al., 2021; Zhang et al., 2023).